Form 4: Aethlon Medical Director Edward Broenniman Reports Stock Transactions
SEC Form 4 Filing
Director Edward Broenniman reports acquisition and disposal of Aethlon Medical (AEMD) common stock and vesting of RSUs.
Summary
- On April 16, 2024, Edward Broenniman, a director of Aethlon Medical Inc. (AEMD), reported transactions involving the company's common stock.
- Broenniman acquired 32,894 shares of common stock at a price of $1.52 per share.
- Broenniman disposed of 45,464 shares of common stock.
- Following the reported transactions, Broenniman directly owns 45,464 shares of AEMD.
- The report also details that Broenniman holds Restricted Stock Units (RSUs) that vest in four equal quarterly installments starting June 30, 2024, and ending March 31, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.
Future Outlook
The vesting schedule of the RSUs indicates future equity compensation for the director.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.
Stakeholder Impact
- Shareholders can use this information to understand the actions of a key company insider.
- The transactions may influence investor sentiment regarding the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/16/2024 | Date of stock acquisition and disposal. |
| 06/30/2024 | First vesting date for RSUs. |
| 09/30/2024 | Second vesting date for RSUs. |
| 12/31/2024 | Third vesting date for RSUs. |
| 03/31/2025 | Final vesting date for RSUs. |
| 04/17/2024 | Date of signature for the Form 4 filing. |
Keywords
Aethlon Medical, AEMD, Edward Broenniman, Form 4, Stock Transaction, Director, RSU, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.